Latest News about TAK
Recent news which mentions TAK
Johnson & Johnson Ends Phase 2 Study For Dengue Antiviral Amid R&D Reprioritization
October 04, 2024
From Benzinga
Protagonist Therapeutics' Two Investigational Candidates Target Over $10B Market, Bullish Analyst Opines
September 10, 2024
From Benzinga
Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
September 09, 2024
From Benzinga
Shortage Relief: More Takeda's Vyvanse For ADHD On the Way As US Ramps Up Production
September 06, 2024
From Benzinga
Ascendis' Hypoparathyroidism Drug Scores FDA Approval As First and Only Treatment, Replacing Takeda's Drug Discontinued Due To Supply Issues
August 12, 2024
From Benzinga
From Benzinga
Tickers
TAK
From InvestorPlace
3 Biotech Stocks to Buy on the Dip: July 2024
July 29, 2024
From InvestorPlace
Newly-Listed Psoriasis-Focused Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation
July 24, 2024
From Benzinga
Eli Lilly's $3.2B Morphic Deal Is 'Crucial,' Has 'Strategic Merit' Despite Investor Attention On Obesity: Analyst
July 09, 2024
From Benzinga
From Benzinga
NextEra Energy, Lennar And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
June 18, 2024
From Benzinga
Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 17, 2024
From Benzinga
What's Going On With Ovid Therapeutics After Takeda's Two Phase 3 Epilepsy Studies Fail?
June 17, 2024
From Benzinga
From Benzinga
7 F-Rated Stocks to Avoid at All Costs in June
June 06, 2024
From InvestorPlace
From Benzinga
From InvestorPlace
From Benzinga
From Benzinga
Why Is AC Immune (ACIU) Stock Up 45% Today?
May 13, 2024
From InvestorPlace
Japan's Takeda Pharma Outlines $900M Overhaul To Boost Growth, As 2023 Profit Fall Over 50%
May 09, 2024
From Benzinga
Tickers
TAK
From InvestorPlace
Neurocrine Biosciences Says Treatment Can Alleviate Several Symptoms Associated With Depressive Disorder
April 23, 2024
From Benzinga
The Hot List: 3 AI Stocks Worth Buying on Weakness
March 01, 2024
From InvestorPlace
From Benzinga
Good News For Sleep Disorder Patients - Takeda's Therapy Shows Promise In Mid-Stage Study
February 09, 2024
From Benzinga
Why Is Japanese Drugmaker Takeda Stock Trading Lower Today?
February 01, 2024
From Benzinga
Earnings Scheduled For February 1, 2024
February 01, 2024
From Benzinga
3 Stocks to Buy to Benefit From the Booming Sleep Industry
January 23, 2024
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.